Lung Cancer

Published by: Elsevier Ireland Ltd.  

People

  1. Kris
    Kris
  2. Rusch
    Rusch
  3. Ginsberg
    Ginsberg
  4. Riely
    Riely
  5. Travis
    Travis
  6. Drilon
    Drilon
  7. Rimner
    Rimner
  8. Ladanyi
    Ladanyi
  9. Miller
    Miller
  10. Zheng
    Zheng

Groups

  1. Department of Medicine (62)
  2. Solid Tumor Oncology Division (58)
  3. Thoracic Oncology (56)
  4. Surgery (36)
  5. Biostatistics Service (19)
  6. Epidemiology and Biostatistics (19)
  7. Radiology, Department of (17)
  8. Survivorship Research (17)
  9. GSK Faculty (16)
  10. Body Imaging Service (14)
Search Within
Formats
  1. Journal Article (81)
  2. Meeting Abstract (39)
  3. Conference Paper (6)
  4. Review (5)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (62)
  2. Solid Tumor Oncology Division (58)
  3. Thoracic Oncology (56)
  4. Surgery (36)
  5. Biostatistics Service (19)
  6. Epidemiology and Biostatistics (19)

More Groups

People
  1. Mark Kris (30)
  2. Valerie Rusch (19)
  3. Lee Krug (18)
  4. Michelle Ginsberg (13)
  5. Gregory Riely (11)
  6. William Travis (10)

More People

Years
  1. 2023 (6)
  2. 2022 (9)
  3. 2021 (9)
  4. 2020 (4)
  5. 2019 (6)
  6. 2018 (3)

More Years

Publishers
  1. Elsevier Ireland Ltd. (133)

Results (133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from a phase 1/2 study
    Meeting Abstract

    Popat, S.; Ramalingam, S.; Zhou, C.; Kim, T.; Yang, J.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Slipping through the cracks: Who is eligible but does not receive a healthcare provider recommendation for lung cancer screening?
    Journal Article

    Williamson, T. J.; Walsh, L. E.; Rawl, S. M.; Carter-Bawa, L.
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Induction and preliminary characterization of neoplastic pulmonary nodules in a transgenic pig model
    Journal Article

    Ghosn, M.; Elsakka, A. S.; Petre, E. N.; Cheleuitte-Nieves, C.; Tammela, T.; Monette, S.; Ziv, E.; Schachtschneider, K. M.; Srimathveeravalli, G.; Yarmohammadi, H.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal masses
    Journal Article

    Mayoral, M.; Pagano, A. M.; Araujo-Filho, J. A. B.; Zheng, J.; Perez-Johnston, R.; Tan, K. S.; Gibbs, P.; Shepherd, A. F.; Rimner, A.; Simone, C. B. 2nd; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review
    Review

    Blakely, C. M.; Weder, W.; Bubendorf, L.; He, J.; Majem, M.; Shyr, Y.; Chaft, J. E.
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Cardiovascular risks of chemo-immunotherapy for lung cancer: A population-based cohort study
    Journal Article

    Chan, J. S. K.; Tang, P.; Ng, K.; Dee, E. C.; Lee, T. T. L.; Chou, O. H. I.; Lee, Y. H. A.; Lau, D. H. H.; Liu, T.; Tse, G.
    Lung Cancer (2022)

    Fulltext@MSK | Save
  • Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease
    Journal Article

    Tan, K. S.; Hsu, M.; Adusumilli, P. S.
    Lung Cancer (2022)

    Fulltext@MSK | Save
  • Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
    Journal Article

    Liu, Y.; Yao, L.; Kalhor, N.; Carter, B. W.; Altan, M.; Blumenschein, G.; Byers, L. A.; Fossella, F.; Gibbons, D. L.; Kurie, J. M.; more...
    Lung Cancer (2022)

    Fulltext@MSK | Save
  • Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Results from the VISION study and local UK experience
    Meeting Abstract

    Cui, W.; Brown, N.; Brown, V.; Bulusu, R.; Denton, A.; Evans, J.; Forster, M.; Papadatos-Pastos, D.; Pellegrino, L.; Walsh, N.; more...
    Lung Cancer (2022)

    Fulltext@MSK | Save

    • Lung Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 01695002 Elsevier Science Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2019
    Lung Cancer 01695002 1995
    Lung Cancer 0169-5002 Elsevier Sci Publ Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 1993
    Lung Cancer 0169-5002 Elsevier Science, Inc.
    Lung Cancer 18728332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier B.V.
    Lung Cancer 1872-8332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 1695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Unknown
    Lung Cancer 01695002 The Author(s)
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Unknown
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2017
    Lung Cancer 01695002 Elsevier B.V.
    Lung Cancer 01695002 2018
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung cancer (Amsterdam, Netherlands) 01695002 Unknown